Halo Commences Formal EU GACP Certification Process for Cannabis Grown at Bophelo in Lesotho, Africa - Seite 2

Indeed 1,000 flowering plants in 8 hoop houses are under production at Bophelo which Halo expects will be harvested in Q2 2020. Moreover, cloning processes with DNA Genetics are underway for February with an anticipated harvest date in Q3 of 2020.

Mr. Sidhu continues, “We are extremely pleased at the speed at which we are realizing our strategic vision for Bophelo. By the time the maiden harvest is complete the facility is expected to be fully certified and ready to export legal cannabis. International exportation is currently an untapped opportunity for Halo and will add sizeable, incremental topline revenue.

We also look forward to delivering innovative strains with the DNA genetics partnership to future harvests. With three grow seasons a year anticipated at Bophelo, we expect to establish ourselves quickly as one of the leading suppliers of consistently high-quality cannabis to regulated international markets.”

About Halo

Halo is a global cannabis extraction company that develops and manufactures quality cannabis oils and concentrates, which are the fastest growing segments in the cannabis industry. Halo is a global leader in cannabis oil and concentrates, having produced over 4.5 million grams of oils and concentrates since inception. The Company has expertise across all major cannabis manufacturing processes, leveraging a variety of proprietary processes and products. The forward-thinking company is led by a strong management team with deep industry knowledge and blue-chip experience. The Company is currently operating in California and Oregon, as well as in Nevada with our partner Just Quality, LLC, and in Lesotho with the 205-hectare Bophelo cultivation zone.

With a consumer-centric focus, Halo will continue to market innovative, branded, and private label products across multiple product categories. Halo recently acquired Dispensary Track platform which will alleviate customer flow constraints experienced by dispensaries and enable direct consumer interaction.

For further information regarding Halo, see Halo’s disclosure documents on SEDAR at www.sedar.com.

About Pharmaconsulta

Pharmaconsulta is an independent consultancy firm based in Malta (EU) specializing in pharmaceutical regulatory affairs. Besides offering consultancy services, they also offer contract manufacture, laboratory analysis and QP batch release through approved suppliers that are all GMP audited and certified. Pharmaconsulta provides specialist advice and assistance with particular emphasis on EU GMP/GDP/GLP guidelines. The services offered include, but are not limited to, EU market penetration, local representation and distribution, contract Responsible/Qualified Person (RP)/(QP) provision, licensing support, dossier submission review, Patient Information Leaflet (PIL) and Summary of Product Characteristics (SPC) origination and printing, advertising review, pharmacovigilance, Standard Operating Procedures creation (SOP) warehousing and logistics, regulatory solutions and strategic planning.